These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2687005

  • 1. Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
    Le Chevalier T, Zabbe C, Gouva S, Cerrina ML, Quoix E, Riviere A, Berthaud P, Prache C, Berille J.
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1651-2. PubMed ID: 2687005
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Fotemustine: muphoran].
    Avril MF.
    Ann Dermatol Venereol; 2007 Dec; 134(12):997-1000. PubMed ID: 18166925
    [No Abstract] [Full Text] [Related]

  • 8. Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.
    Le Cesne A, Chabot G, Bérille J, Lucas C, Baud M, Gouyette A, Marty M, Le Chevalier T.
    Lung Cancer; 1995 Aug; 13(1):69-78. PubMed ID: 8528641
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neurological toxicity during metastatic melanoma treatment with fotemustine.
    Khalil Z, Pageot N, Carlander B, Guillot B.
    Melanoma Res; 2005 Dec; 15(6):563-4. PubMed ID: 16314745
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma.
    Gill S, Shapiro J, Westerman D, Prince HM.
    J Clin Oncol; 2007 Oct 01; 25(28):4493-4. PubMed ID: 17906211
    [No Abstract] [Full Text] [Related]

  • 14. Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group).
    Rougier P, van Pottelsberghe C, Kok T, Paillot B, Wagener T, De Greve J, Fabri MC, Gerard B, Van Glabbeke M, Bleiberg H.
    Eur J Cancer; 1996 Jul 01; 32A(8):1432-3. PubMed ID: 8869111
    [Abstract] [Full Text] [Related]

  • 15. Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer.
    Rougier P, Chabot GG, Bonneterre J, Tigaud JM, Lucas C, Baud M, Bérille J, Gouyette A.
    Eur J Cancer; 1993 Jul 01; 29A(2):288-9. PubMed ID: 8422301
    [No Abstract] [Full Text] [Related]

  • 16. Phase Ii trial of fotemustine in advanced colorectal cancer.
    Bleiberg H, Becquart D, Michel J, Cavalli F, Gerard B.
    Eur J Cancer; 1990 Jul 01; 26(11-12):1260-1. PubMed ID: 2150002
    [No Abstract] [Full Text] [Related]

  • 17. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct 01; 38(8):876-80. PubMed ID: 2274396
    [No Abstract] [Full Text] [Related]

  • 18. Positive phase II study in the treatment of advanced malignant melanoma with fotemustine.
    Schallreuter KU, Wenzel E, Brassow FW, Berger J, Breitbart EW, Teichmann W.
    Cancer Chemother Pharmacol; 1991 Oct 01; 29(1):85-7. PubMed ID: 1742855
    [Abstract] [Full Text] [Related]

  • 19. Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma.
    Calabresi F, Aapro M, Becquart D, Dirix L, Wils J, Ardizzoni A, Gerard B.
    Ann Oncol; 1991 May 01; 2(5):377-8. PubMed ID: 1954183
    [No Abstract] [Full Text] [Related]

  • 20. Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinoma.
    Lasset C, Merrouche Y, Negrier S, Rebattu P, Berille J, Bizzari JP, Chauvin F, Philip T.
    Cancer Chemother Pharmacol; 1993 May 01; 32(4):329-31. PubMed ID: 8324878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.